Zheng Li-yan, Xi Yong-zhi, Kong Fan-hua, Cui Jian-wu, Liang Fei, Liu Nan, Sun Yu-ying, Guo Si-qi
Department of Immunology, Affiliated Hospital for Academy of Military Medical Sciences, National Center of Biomedical Analysis Lab. of Immunoassay, Beijing 100039, China.
Zhonghua Yi Xue Za Zhi. 2003 Jul 25;83(14):1246-50.
A novel recombinant interleukin6-Pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemic cells highly expressing IL6R has been molecularly designed and constructed in this study.
Firstly, REDLK at C-terminus of Pseudomonas exotoxin PE40 was replaced with KDEL using point mutagenesis technology. Secondly, a cDNA encoding interleukin-6 devoid of N-terminal 24 amino acids [IL6D24] was fused to 5' terminus of PE40KDEL DNA by the method of gene splicing by overlap extension, which could generate recombinant IL6D24-PE40KDEL and IL6D24-Linker-PE40KDEL fusion genes. Thirdly, recombinant fusion genes IL6D24-PE40KDEL and IL6D24-Linker-PE40KDEL were ligated into the EcoR I and Sma I cloning sites in the pBV220 plasmids respectively and then transformed into E.coli HB101 cells. The expressed recombinant exotoxin fusion proteins were purified to electrophoresis purity by Mono Q column chromatography. Its selectively killing was tested by the MTS colorimetric method using both U937 and CEM cells lines.
Recombinant exotoxin fusion proteins IL6D24-PE40KDEL was expressed as a form of inclusion bodies at higher level of 40% approximately of total proteins in bacterial cells. Western blot showed that the purified products could react specifically with IL6 monoclonal antibody and PEA antiserum, respectively. IL6D24-PE40KDEL was selectively cytotoxic to U937 cells expressing IL6R-positive with ID50 of 250 ng/ml, and but not CEM cells expressing IL6R-negative.
Two novel recombinant interleukin6-Pseudomonas exotoxin fusion proteins IL6D24-PE40KDEL and IL6D24-Linker-PE40KDEL have been successfully constructed and they can selectively kill the leukemic cells expressing highly IL6R.
本研究分子设计并构建了一种对高表达IL6R的白血病细胞具有靶向细胞毒性的新型重组白细胞介素6 - 铜绿假单胞菌外毒素融合蛋白。
首先,利用点突变技术将铜绿假单胞菌外毒素PE40 C末端的REDLK替换为KDEL。其次,通过重叠延伸基因拼接方法,将编码缺失N末端24个氨基酸的白细胞介素-6的cDNA[IL6D24]融合至PE40KDEL DNA的5'末端,可产生重组IL6D24 - PE40KDEL和IL6D24 - Linker - PE40KDEL融合基因。第三,将重组融合基因IL6D24 - PE40KDEL和IL6D24 - Linker - PE40KDEL分别连接至pBV220质粒的EcoR I和Sma I克隆位点,然后转化至大肠杆菌HB101细胞。通过Mono Q柱层析将表达的重组外毒素融合蛋白纯化至电泳纯。使用U937和CEM细胞系通过MTS比色法测试其选择性杀伤作用。
重组外毒素融合蛋白IL6D24 - PE40KDEL以包涵体形式表达,在细菌细胞中约占总蛋白的40%,表达水平较高。蛋白质印迹法显示纯化产物可分别与IL6单克隆抗体和PEA抗血清特异性反应。IL6D24 - PE40KDEL对表达IL6R阳性的U937细胞具有选择性细胞毒性,ID50为250 ng/ml,但对表达IL6R阴性的CEM细胞无细胞毒性。
成功构建了两种新型重组白细胞介素6 - 铜绿假单胞菌外毒素融合蛋白IL6D24 - PE40KDEL和IL6D24 - Linker - PE40KDEL,它们可选择性杀伤高表达IL6R的白血病细胞。